Changes after publication
September 2013: correction to show that recommendation 1.5 had been updated by TA209, rather than recommendation 1.4.
March 2012: minor maintenance.
November 2010: This guidance has been partially updated by 'Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours' (NICE technology appraisal guidance 209). The changes are shown in section 1.